Search Results - Agrawal, Sapeck

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract C031: A randomized Phase 1b study of IGM-8444 in combination with FOLFIRI + bevacizumab compared to FOLFIRI + bevacizumab alone in second line metastatic colorectal cancer

    Abstract C031: A randomized Phase 1b study of IGM-8444 in combination with FOLFIRI + bevacizumab compared to FOLFIRI + bevacizumab alone in second line metastatic colorectal cancer by Ulahannan, Susanna, Pelster, Meredith, LoRusso, Patricia, Falchook, Gerald, Wang, Judy, Barve, Minal, Grewal, Jaspreet, Chow, Warren, Henry, Jason, Cecchini, Michael, Subbiah, Vivek, Leabman, Maya, Hernandez, Genevive, Li, Yao, Sinclair, Angus, Wang, Beatrice, Kotturi, Maya, Humke, Eric, Ahern, Sean, Ennis, Leslie, Caruano, Melaine, Agrawal, Sapeck

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    2753. Induction of Broadly Cross-Reactive Immune Responses Against A(H3N2) Airuses: Results of a Phase 2 Trial of a Novel Recombinant Hemagglutinin Saponin-Adjuvanted Nanoparticle Seasonal Influenza Vaccine

    2753. Induction of Broadly Cross-Reactive Immune Responses Against A(H3N2) Airuses: Results of a Phase 2 Trial of a Novel Recombinant Hemagglutinin Saponin-Adjuvanted Nanoparticle... by Shinde, Vivek, Cai, Rongman, Plested, Joyce S, Zhou, Bin, Zhou, Haixia, Zhu, Mingzhu, Wang, Nan, Cloney-Clark, Shane, Agrawal, Sapeck, Spindler, Michelle S, Patel, Nita, Massare, Michael, Smith, Gale, Thomas, D Nigel, Cho, Iksung, Fries, Louis F, Glenn, Gregory M

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: